Newborn screening for SMA in Southern Belgium
Approval was recently granted for a new treatment for spinal muscular atrophy (SMA). Given that the treatment is effective when administered early and the societal burden of SMA-related disability, the implementation of a newborn screening program is warranted. We describe the stepwise process that led us to launch a newborn screening program for SMA in Southern Belgium. Different political, ethical, and clinical partners were informed about this project and were involved in its governance, as were genetic and screening labs. We developed and validated a newborn screening method to specificall... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2019 |
Reihe/Periodikum: | Boemer , F , Caberg , J-H , Dideberg , V , Dardenne , D , Bours , V , Hiligsmann , M , Dangouloff , T & Servais , L 2019 , ' Newborn screening for SMA in Southern Belgium ' , Neuromuscular Disorders , vol. 29 , no. 5 , pp. 343-349 . https://doi.org/10.1016/j.nmd.2019.02.003 |
Schlagwörter: | Spinal muscular atrophy / Werdnig-Hoffmann disease / Newborn screening / SMN1 / qPCR / SPINAL MUSCULAR-ATROPHY / SHAM CONTROL / NUSINERSEN / MECHANISMS |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26597384 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://cris.maastrichtuniversity.nl/en/publications/c8d2b6c8-389c-4a65-b040-f1e3bfe2ca90 |